Marion Biotech, the Indian pharmaceutical company whose cough syrups were linked to the deaths of 65 children in Uzbekistan last year, will have to submit a report of "corrective and preventive action" before being allowed to reopen its factory in Uttar Pradesh. The state's drug controller stated that the company could resume production and sale of items that do not contain the ingredient linked to the deaths, but did not give a timeline for resumption.